Roche Holding AG will launch two locally branded cancer drugs in India at "significantly lower" prices by the end of this year or early next year, a Roche spokesman said on Friday.
Roche has tied-up with Emcure Pharmaceuticals Ltd to launch local brands of its Herceptin and Mabthera cancer drugs, Daniel Grotzky said in a phone interview from the company headquarters in Basel, Switzerland.
"The scope is to enable access for a large majority of patients who currently pay out of pocket as well as to partner with the government to enable increased access to our products for people in need," he said.
